Patients with Minimal Hepatic Encephalopathy Have Poor Insight into Their Driving Skills
Overview
Affiliations
Background & Aims: Minimal hepatic encephalopathy (MHE) is associated with impaired driving skills. It is not clear whether patients have insight into this. The Driving Behavior Survey (DBS) is a validated self- or observer-administered questionnaire. DBS consists of a total score (maximum, 104) and an attention-related driving skills section (maximum, 40). DBS was used to compare self-assessment with observer-assessment of driving skills in cirrhotic patients tested for MHE.
Methods: Forty-seven nonalcoholic cirrhotic patients and 40 controls underwent psychometric tests, DBS, and driving simulation with navigation/driving tasks. An adult familiar with the subject's driving completed the DBS independently. Simulator performances, total DBS scores, and driving skill scores were compared between/within groups (MHE+, MHE-, and controls) with respect to self-assessment and observer assessment.
Results: Thirty-six patients were MHE+ and 11 were MHE-. MHE+ had a significantly higher simulator crash (MHE+, 3; MHE-, 1.2; controls, 1.7; P = .001) and illegal turn rate (MHE+, 1.2; MHE-, 0.3; controls, 0.1; P = .0001). Despite this worse performance, MHE+ patients rated themselves similar to MHE- patients and control groups on total (P = .28) and driving skills scores (P = .19). Observer assessment in MHE+ was significantly lower for total (P = .0001) and driving skills (P = .0001) compared with observer assessment for MHE- patients and control groups. MHE+ patients were rated significantly lower on driving skills (34 vs 37; P = .02) and trended lower in the total score (P = .08) by observers compared with self-ratings. In contrast, MHE- and control groups rated themselves similar to their observers on driving skills and total DBS scores.
Conclusions: MHE patients have poor insight into their driving skills. A part of the MHE patient's clinical interview should be to increase awareness of this driving impairment.
Faccioli J, Nardelli S, Gioia S, Riggio O, Ridola L J Clin Med. 2022; 11(23).
PMID: 36498820 PMC: 9736966. DOI: 10.3390/jcm11237246.
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.
Louissaint J, Deutsch-Link S, Tapper E Clin Gastroenterol Hepatol. 2022; 20(8S):S1-S8.
PMID: 35940729 PMC: 9531320. DOI: 10.1016/j.cgh.2022.04.036.
Haussinger D, Dhiman R, Felipo V, Gorg B, Jalan R, Kircheis G Nat Rev Dis Primers. 2022; 8(1):43.
PMID: 35739133 DOI: 10.1038/s41572-022-00366-6.
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy.
Di Cola S, Nardelli S, Ridola L, Gioia S, Riggio O, Merli M J Clin Med. 2022; 11(3).
PMID: 35160063 PMC: 8836353. DOI: 10.3390/jcm11030611.
Janyajirawong R, Vilaichone R, Sethasine S Asian Pac J Cancer Prev. 2021; 22(9):2879-2887.
PMID: 34582657 PMC: 8850891. DOI: 10.31557/APJCP.2021.22.9.2879.